Core Points - The independent directors of 23andMe Holding Co. have resigned from the Board, effective immediately, due to a lack of actionable proposals from the CEO that align with the interests of non-affiliated shareholders [1][2]. - The directors expressed their support for the company's mission but indicated a fundamental disagreement on the strategic direction moving forward, exacerbated by the CEO's concentrated voting power [3]. - The resignation reflects a desire to avoid prolonged conflict regarding the company's future direction, emphasizing the importance of shareholder interests [2][3]. Company Overview - 23andMe is a genetics-led consumer healthcare and biopharmaceutical company focused on empowering a healthier future through direct access to genetic information [4].
Independent Directors of 23andMe Resign from Board